0001209191-22-032316.txt : 20220526
0001209191-22-032316.hdr.sgml : 20220526
20220526181554
ACCESSION NUMBER: 0001209191-22-032316
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220525
FILED AS OF DATE: 20220526
DATE AS OF CHANGE: 20220526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lyons-Williams Lori
CENTRAL INDEX KEY: 0001693564
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38997
FILM NUMBER: 22971883
MAIL ADDRESS:
STREET 1: C/O DERMIRA, INC.
STREET 2: 275 MIDDLEFIELD ROAD, SUITE 150
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RAPT Therapeutics, Inc.
CENTRAL INDEX KEY: 0001673772
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473313701
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 489-9000
MAIL ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FLX Bio, Inc.
DATE OF NAME CHANGE: 20160504
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-25
0
0001673772
RAPT Therapeutics, Inc.
RAPT
0001693564
Lyons-Williams Lori
C/O RAPT THERAPEUTICS, INC.
561 ECCLES AVENUE
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (right to buy)
13.64
2022-05-25
4
A
0
8500
0.00
A
2032-05-24
Common Stock
8500
8500
D
The Option shall vest on the earlier of (i) May 25, 2023, or (ii) one day prior to the date of the Issuer's next annual meeting of stockholders to be held in 2023, subject to the Reporting Person's continuous service through each applicable vesting date.
/s/ Rodney Young, Attorney-in-Fact for Lori Lyons-Williams
2022-05-26